| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Vivoryon Therapeutics N.V (AS: VVY)
VVY Technical Analysis
5
| As on 8th May 2025 VVY STOCK Price closed @ 1.76 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.63 & Strong Sell for SHORT-TERM with Stoploss of 8.13 we also expect STOCK to react on Following IMPORTANT LEVELS. |
VVYSTOCK Price
| Open | 1.74 | Change | Price | % |
| High | 1.76 | 1 Day | 0.02 | 1.15 |
| Low | 1.74 | 1 Week | -0.04 | -2.22 |
| Close | 1.76 | 1 Month | -0.22 | -11.11 |
| Volume | 14900 | 1 Year | -5.93 | -77.11 |
| 52 Week High 9.68 | 52 Week Low 0.42 | ||||
AS Netherlands Most Active Stocks
| PHARM | 0.89 | 17.11% |
| RDSA | 22.80 | -1.08% |
| INGA | 17.99 | 1.24% |
| KPN | 4.06 | -1.69% |
| AGN | 5.95 | 0.34% |
| PHIA | 21.43 | 0.61% |
| PRX | 43.37 | 2.87% |
| AD | 36.50 | -2.67% |
| UMG | 26.76 | -0.85% |
| PNL | 0.89 | 2.30% |
AS Netherlands Top Gainers Stocks
AS Netherlands Top Losers Stocks
| VVY Daily Charts |
VVY Intraday Charts |
Whats New @ Bazaartrend |
VVY Free Analysis |
|
|
VVY Important Levels Intraday
| RESISTANCE | 1.80 |
| RESISTANCE | 1.79 |
| RESISTANCE | 1.78 |
| RESISTANCE | 1.77 |
| SUPPORT | 1.75 |
| SUPPORT | 1.74 |
| SUPPORT | 1.73 |
| SUPPORT | 1.72 |
VVY Forecast May 2025
| 4th UP Forecast | 4.07 |
| 3rd UP Forecast | 3.33 |
| 2nd UP Forecast | 2.87 |
| 1st UP Forecast | 2.41 |
| 1st DOWN Forecast | 1.11 |
| 2nd DOWN Forecast | 0.65 |
| 3rd DOWN Forecast | 0.19 |
| 4th DOWN Forecast | -0.55 |
VVY Weekly Forecast
| 4th UP Forecast | 2.55 |
| 3rd UP Forecast | 2.30 |
| 2nd UP Forecast | 2.14 |
| 1st UP Forecast | 1.98 |
| 1st DOWN Forecast | 1.54 |
| 2nd DOWN Forecast | 1.38 |
| 3rd DOWN Forecast | 1.22 |
| 4th DOWN Forecast | 0.97 |
VVY Forecast2025
| 4th UP Forecast | 20.11 |
| 3rd UP Forecast | 14.22 |
| 2nd UP Forecast | 10.59 |
| 1st UP Forecast | 6.95 |
| 1st DOWN Forecast | -3.43 |
| 2nd DOWN Forecast | -7.07 |
| 3rd DOWN Forecast | -10.7 |
| 4th DOWN Forecast | -16.59 |
Vivoryon Therapeutics N.V ( AS Netherlands Symbol : VVY )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
VVY Business Profile
Vivoryon Therapeutics N.V., a clinical stage biopharmaceutical company, engages in the research and development of therapeutic products for the treatment of Alzheimer's disease. Its pipeline products target toxic pyroglutamate-Abeta (pGlu-Abeta), which inhibits the production of pGlu-Abeta. The company's lead product candidate is PQ912, a small molecule QC inhibitor that has completed Phase IIb clinical trials for use in the treatment of Alzheimer's disease; and for the treatment of cancer. Its preclinical development product is PQ1565, a small molecule glutaminyl-peptide cyclotransferase-like inhibitor for the treatment of cancer. In addition, the company is developing a monoclonal antibody targeting pGlu-Abeta to enhance its clearance. Vivoryon Therapeutics N.V. has a research collaboration agreement with University Medical Center Schleswig-Holstein to discover and develop therapeutics in cancer immunotherapy; collaboration agreement with Nordic Bioscience for the clinical development of PQ912 for Alzheimer's disease; and research collaboration with the Fraunhofer Institute for cell therapy and immunology, as well as a strategic regional licensing partnership with Simcere Pharmaceutical Group Ltd. to develop and commercialize medicines targeting the neurotoxic amyloid species N3pE (pGlu-Abeta) to treat Alzheimer's disease. Vivoryon Therapeutics N.V. was founded in 1997 and is headquartered in Halle, Germany. Address: Weinbergweg 22, Halle, Germany, 06120
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service